Christopher G. White - 13 Oct 2022 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUL	Stock Option (Right to Buy)	Award	$0	+7,000		$0.000000	7,000	13 Oct 2022	Common Stock	7,000	$4.19	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.